Serina Therapeutics (SER) Earnings Date & Reports

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SER is expected to report earnings to fall 24.56% to -41 cents per share on November 18

Serina Therapeutics SER Stock Earnings Reports

Q3'26

Est.

$-0.41

Q2'26

Missed

by $0.09

The last earnings report on August 13 showed earnings per share of -55 cents, missing the estimate of -46 cents. With 17.41K shares outstanding, the current market capitalization sits at 68.33M.

View a ticker or compare two or three

SER

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days